Part 5/8:
Dr. Oz noted that the administration had reached out to all leading pharmaceutical firms, including Eli Lilly, which some speculate might also enter into similar agreements. The administration’s goal is to strike a balance—support innovation and medical advancement while controlling costs. This approach recognizes that pharmaceutical companies need sufficient incentives to continue groundbreaking research and develop treatments for cancer, autoimmune diseases, Alzheimer’s, obesity, and more.